valproic acid has been researched along with inositol in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (3.45) | 18.2507 |
2000's | 41 (70.69) | 29.6817 |
2010's | 11 (18.97) | 24.3611 |
2020's | 4 (6.90) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Lenox, RH; McNamara, RK; Watson, DG; Watterson, JM | 1 |
Lubrich, B; van Calker, D | 1 |
Belmaker, RH; Bersudsky, Y; Hertz, L; Simkin, M; Wolfson, M; Zinger, E | 1 |
Bodor, N; Bruno-Blanch, L; Moon, SC | 1 |
Greenberg, ML; Murray, M | 1 |
Hanstock, CC; Nakashima, TT; O'Donnell, T; Rotzinger, S; Silverstone, PH; Ulrich, M | 2 |
Babb, SM; Breeze, JL; Cohen, BM; Frederick, BB; Gruber, SA; Hennen, J; Moore, CM; Renshaw, PF; Stoll, AL; Villafuerte, RA; Yurgelun-Todd, DA | 1 |
Belmaker, RH; van Calker, D | 1 |
Buttenfield, J; Chengappa, KN; Gershon, S; Hardan, A; Kupfer, DJ; Levine, J; Luther, J; Mallinger, AG; Pollock, B; Vagnucci, A; Verfaille, S | 1 |
Ding, D; Greenberg, ML; Peterson, B; Vaden, DL | 1 |
Belmaker, RH; Ding, D; Greenberg, ML; Ju, S; Shaldubina, A; Vaden, DL | 1 |
Klisch, J; Schumacher, M; Spreer, J; Thiel, T; Ziyeh, S | 1 |
Asghar, SJ; Hanstock, CC; O'Donnell, T; Silverstone, PH; Ulrich, M; Wu, RH | 2 |
Agam, G; Greenberg, ML; Shaltiel, G; Shamir, A | 1 |
Greenberg, ML; Zhong, Q | 1 |
Agam, G; Harwood, AJ | 1 |
Koyama, T; Nakagawa, S | 1 |
Greenberg, ML; Ju, S | 1 |
Barker, GJ; Duncan, JS; McLean, MA; Simister, RJ | 2 |
Agam, G; Greenberg, ML; Ju, S; Shaltiel, G; Shamir, A | 1 |
Basta-Kaim, A; Budziszewska, B; Jaworska-Feil, L; Kubera, M; Lasoń, W; Leśkiewicz, M; Tetich, M | 1 |
Harwood, AJ | 1 |
Agam, G; Belmaker, RH; Bialer, M; Dalton, E; Ding, D; Greenberg, ML; Harwood, AJ; Shaltiel, G; Shamir, A; Shapiro, J | 1 |
Kim, H; McGrath, BM; Silverstone, PH | 1 |
Ding, D; Geiger, JH; Greenberg, ML; Ju, S; Shi, Y; Vaden, DL | 1 |
Finnell, RH; Giavini, E; Massa, V; Wlodarczyk, B | 1 |
Culhane, M; Demopulos, C; Eden Evins, A; Grandin, LD; Nierenberg, AA; Ogutha, J; Sachs, GS; Yovel, I | 1 |
Agam, G; Belmaker, RH; Dalton, EC; Harwood, AJ; Shaltiel, G | 1 |
Bruno-Blanch, LE; Echeverría, GA; Ellena, J; Moon, SC; Punte, G | 1 |
Greenshaw, AJ; McGrath, BM; McKay, R; Silverstone, PH; Slupsky, CM | 1 |
Nurrish, SJ; Saiardi, A; Tokuoka, SM | 1 |
Agam, G; Azab, AN; Campbell, A; Ding, D; Greenberg, ML; Mehta, DV; Pullumbi, E; Shaltiel, G; Shi, Y | 1 |
Azab, AN; Chesebro, JE; Greenberg, ML; Mehta, DV | 1 |
Buechert, M; Garcia, M; Huppertz, HJ; Mader, I; Schumacher, M; Ziyeh, S | 1 |
Moses, A; Potter, M; Wozniak, J | 1 |
Dalton, E; Harwood, AJ; King, J; Ryves, J; Teo, R; Williams, RS | 1 |
Terbach, N; Williams, RS | 1 |
Di Daniel, E; Kew, JN; Maycox, PR | 1 |
McGrath, BM; Silverstone, PH | 1 |
Bialer, M; Chang, P; Deranieh, RM; Dham, M; Greenberg, ML; Hoeller, O; Orabi, B; Shimshoni, JA; Walker, MC; Williams, RS; Yagen, B | 1 |
Chaieb, L; Eikel, D; Elphick, LM; Guschina, IA; Harwood, JL; Nau, H; Pawolleck, N; Plant, NJ; Williams, RS | 1 |
Caruso, JA; Deranieh, RM; Greenberg, ML; He, Q | 1 |
Bellivier, F; Etain, B; Geoffroy, PA; Leboyer, M | 1 |
Greenberg, ML; Ye, C | 1 |
Chen, Y; Deranieh, RM; Greenberg, ML; Kane, PM; McCaffery, JM; Shi, Y; Tarsio, M | 1 |
Cowart, LA; Greenberg, ML; Jadhav, S; Russo, S | 1 |
Daniel, J; Greenberg, ML; Maddipati, KR; Mehta, D; Yu, W | 1 |
Jagadeesan, R; Kothandan, G; Kumar, D; Kumar, N; Saha, S; Sinha, M | 1 |
D'Ambrosio, F; Di Lorenzo, C; Janiri, L | 1 |
Greenberg, ML; Lazcano, P; Onu, CJ; Schmidtke, MW | 1 |
Cantelmi, T; Lepore, E; Unfer, V; Unfer, VR | 1 |
12 review(s) available for valproic acid and inositol
Article | Year |
---|---|
The high affinity inositol transport system--implications for the pathophysiology and treatment of bipolar disorder.
Topics: Antimanic Agents; Biological Transport, Active; Bipolar Disorder; Carbamazepine; Carrier Proteins; Down-Regulation; Heat-Shock Proteins; Humans; Inositol; Lithium Compounds; Membrane Proteins; Symporters; Valproic Acid | 2000 |
Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Blood Cells; Enzyme Inhibitors; Eukaryotic Cells; Humans; Inositol; Lithium; Models, Biological; Phosphoric Monoester Hydrolases; Prefrontal Cortex; Saccharomyces cerevisiae; Valproic Acid | 2002 |
Search for a common mechanism of mood stabilizers.
Topics: Affect; Animals; Anticonvulsants; Antimanic Agents; Carbamazepine; Glycogen Synthase Kinase 3; Humans; Inositol; Lithium; Mood Disorders; Signal Transduction; Valproic Acid | 2003 |
[Mechanism and clinical effects of drugs for mood disorder].
Topics: Antidepressive Agents; Antimanic Agents; Biogenic Monoamines; Humans; Inositol; Lithium; Meta-Analysis as Topic; Mood Disorders; Secondary Prevention; Synapses; Treatment Outcome; Valproic Acid | 2003 |
Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain; Humans; Inositol; Lithium Compounds; Signal Transduction; Valproic Acid | 2005 |
Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Basal Ganglia; Bipolar Disorder; Frontal Lobe; Gyrus Cinguli; Humans; Inositol; Lithium Carbonate; Magnetic Resonance Spectroscopy; Temporal Lobe; Valproic Acid | 2005 |
Alternative treatments in pediatric bipolar disorder.
Topics: Acupuncture; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Child; Humans; Hypericum; Inositol; Lecithins; Lithium Carbonate; Melatonin; S-Adenosylmethionine; Valproic Acid | 2009 |
Structure-function studies for the panacea, valproic acid.
Topics: Animals; Anticonvulsants; Bipolar Disorder; Epilepsy; gamma-Aminobutyric Acid; Glycogen Synthase Kinase 3; HIV Infections; Humans; Inositol; Ion Channels; Migraine Disorders; Mitogen-Activated Protein Kinases; Molecular Structure; Phospholipases A2; Phospholipids; Signal Transduction; Structure-Activity Relationship; Teratogens; Valproic Acid; Virus Latency | 2009 |
Investigation of the H(+)-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling.
Topics: Animals; Antimanic Agents; Brain; Carbamazepine; Glucose Transport Proteins, Facilitative; Humans; Inositol; Lithium Compounds; Membrane Transport Proteins; Neurons; Phosphatidylinositols; Signal Transduction; Valproic Acid | 2009 |
Lithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patients.
Topics: Affect; Animals; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Brain; Humans; Inositol; Lithium Carbonate; Magnetic Resonance Spectroscopy; Reference Values; Second Messenger Systems; Treatment Outcome; Ubiquitin-Protein Ligases; Valproic Acid | 2009 |
Can the response to mood stabilizers be predicted in bipolar disorder?
Topics: Antimanic Agents; Bipolar Disorder; Circadian Rhythm Signaling Peptides and Proteins; Genetic Association Studies; Genome-Wide Association Study; Humans; Inositol; Lithium; Neurotransmitter Agents; Pharmacogenetics; Phenotype; Valproic Acid | 2014 |
Combined treatment of myo-inositol and d-chiro-inositol (80:1) as a therapeutic approach to restore inositol eumetabolism in patients with bipolar disorder taking lithium and valproic acid.
Topics: Antimanic Agents; Bipolar Disorder; Dietary Supplements; Humans; Inositol; Lithium Compounds; Medication Adherence; Quality of Life; Valproic Acid | 2021 |
5 trial(s) available for valproic acid and inositol
Article | Year |
---|---|
Inositol as an add-on treatment for bipolar depression.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Blood-Brain Barrier; Carbamazepine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Inositol; Lithium; Male; Middle Aged; Pilot Projects; Treatment Outcome; Valproic Acid | 2000 |
Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
Topics: Adult; Algorithms; Antimanic Agents; Bipolar Disorder; Brain Chemistry; Female; Frontal Lobe; Humans; Inositol; Lithium; Magnetic Resonance Spectroscopy; Male; Phosphatidylinositols; Psychiatric Status Rating Scales; Temporal Lobe; Valproic Acid | 2002 |
Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Aspartic Acid; Bipolar Disorder; Cerebral Cortex; Choline; Creatine; Drug Administration Schedule; Female; Humans; Inositol; Lithium; Magnetic Resonance Spectroscopy; Male; Phosphocreatine; Valproic Acid | 2003 |
Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Aspartic Acid; Carnosine; Epilepsy, Generalized; Female; Frontal Lobe; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Reference Values; Valproic Acid | 2003 |
Inositol augmentation of lithium or valproate for bipolar depression.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Brief Psychiatric Rating Scale; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Inositol; Lithium Carbonate; Male; Middle Aged; Sensitivity and Specificity; Severity of Illness Index; Surveys and Questionnaires; Valproic Acid | 2006 |
41 other study(ies) available for valproic acid and inositol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Topics: Animals; Bipolar Disorder; Blotting, Western; Carbamazepine; Cell Line; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Gene Expression; Hippocampus; Humans; Inositol; Intracellular Signaling Peptides and Proteins; Lithium Chloride; Membrane Proteins; Myristoylated Alanine-Rich C Kinase Substrate; Neurons; Protein Biosynthesis; Protein Kinase C; Proteins; Rabbits; Rats; Valproic Acid | 1996 |
Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs?
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Antimanic Agents; Astrocytes; Biological Transport; Brain; Carbamazepine; Carrier Proteins; Heat-Shock Proteins; Humans; Inositol; Lithium; Membrane Proteins; Rats; Rats, Wistar; RNA, Messenger; Symporters; Time Factors; Tumor Cells, Cultured; Valproic Acid | 1999 |
Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations.
Topics: Antimanic Agents; Astrocytoma; Bipolar Disorder; Brain; Brain Neoplasms; Carbamazepine; Dose-Response Relationship, Drug; Humans; Inositol; Lithium Chloride; Signal Transduction; Tritium; Tumor Cells, Cultured; Valproic Acid | 2000 |
Synthesis and pharmacological evaluation of prodrugs of valproic acid.
Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Electroshock; Inositol; Magnetic Resonance Spectroscopy; Mice; Postural Balance; Prodrugs; Valproic Acid | 2000 |
Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate.
Topics: Amino Acid Sequence; Animals; Carbon; Cattle; Escherichia coli; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Genotype; Humans; Inositol; Lithium; Molecular Sequence Data; Open Reading Frames; Phosphoric Monoester Hydrolases; Recombinant Fusion Proteins; Saccharomyces cerevisiae; Sequence Alignment; Sequence Homology, Amino Acid; Valproic Acid; Xenopus laevis | 2000 |
Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.
Topics: Animals; Brain; Dextroamphetamine; Inositol; Inositol Phosphates; Lithium Chloride; Magnetic Resonance Spectroscopy; Male; Models, Chemical; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Valproic Acid | 2000 |
Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex.
Topics: Adult; Affect; Bipolar Disorder; Brain Mapping; Choline; Dominance, Cerebral; Female; Gyrus Cinguli; Humans; Inositol; Lithium Carbonate; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphocreatine; Psychiatric Status Rating Scales; Valproic Acid | 2000 |
Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis.
Topics: Basic Helix-Loop-Helix Transcription Factors; DNA-Binding Proteins; Fungal Proteins; Gene Expression Regulation, Fungal; Genes, Fungal; Inositol; Lithium; Repressor Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Transcription Factors; Valproic Acid | 2001 |
Epi-inositol regulates expression of the yeast INO1 gene encoding inositol-1-P synthase.
Topics: Anticonvulsants; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Inositol; Isomerism; Lithium; Myo-Inositol-1-Phosphate Synthase; Saccharomyces cerevisiae; Valproic Acid | 2002 |
Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy.
Topics: Adult; Anticonvulsants; Aspartic Acid; Brain; Brain Diseases, Metabolic; Choline; Creatine; Epilepsy; Glutamic Acid; Glutamine; Humans; Hyperammonemia; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Occipital Lobe; Valproic Acid | 2002 |
Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain.
Topics: Animals; Anticonvulsants; Brain Chemistry; Central Nervous System Stimulants; Creatine; Dextroamphetamine; Glucose-6-Phosphate; Glycine; Inositol; Inositol Phosphates; Lithium; Magnetic Resonance Spectroscopy; Male; Phosphocreatine; Phosphorylcholine; Rats; Rats, Sprague-Dawley; Valproic Acid | 2003 |
Regulation of phosphatidylglycerophosphate synthase by inositol in Saccharomyces cerevisiae is not at the level of PGS1 mRNA abundance.
Topics: Blotting, Northern; Carbon; CDPdiacylglycerol-Serine O-Phosphatidyltransferase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Gene Expression Regulation; Gene Expression Regulation, Fungal; Genotype; Glucose; Glycerol; Inositol; Mitochondria; Mutation; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Time Factors; Transcription, Genetic; Valproic Acid | 2003 |
Valproate disrupts regulation of inositol responsive genes and alters regulation of phospholipid biosynthesis.
Topics: 5' Untranslated Regions; Basic Helix-Loop-Helix Transcription Factors; Blotting, Northern; CDPdiacylglycerol-Serine O-Phosphatidyltransferase; Cell Division; Electrophoresis, Agar Gel; Gene Expression Regulation, Fungal; Inositol; Myo-Inositol-1-Phosphate Synthase; Nucleic Acid Hybridization; Phospholipids; Repressor Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Transcription Factors; Valproic Acid | 2003 |
Human 1-D-myo-inositol-3-phosphate synthase is functional in yeast.
Topics: Amino Acid Sequence; Blotting, Western; Cations; Cloning, Molecular; DNA, Complementary; Dose-Response Relationship, Drug; Escherichia coli; Humans; Hydrogen-Ion Concentration; Inositol; Intramolecular Lyases; Kinetics; Molecular Sequence Data; Mutation; Recombinant Proteins; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Temperature; Time Factors; Valproic Acid | 2004 |
Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.
Topics: Amphetamine; Animals; Anthracenes; Antimanic Agents; Blotting, Western; Carbamazepine; Cell Line; Cell Survival; Chloramphenicol O-Acetyltransferase; Corticosterone; Dose-Response Relationship, Drug; Flavonoids; Gene Expression Regulation, Enzymologic; Imidazoles; Indoles; Inositol; Lithium; Maleimides; Protein Kinase C; Protein Kinase C-alpha; Pyridines; Receptors, Glucocorticoid; Tamoxifen; Tetradecanoylphorbol Acetate; Valproic Acid | 2004 |
Valproate decreases inositol biosynthesis.
Topics: Amides; Animals; Animals, Newborn; Anticonvulsants; Blotting, Northern; Brain Chemistry; Cells, Cultured; Chromatography, Gas; Cyclopropanes; Dose-Response Relationship, Drug; Ganglia, Spinal; Gene Expression; Humans; In Vitro Techniques; Inositol; Male; Mice; Mice, Inbred ICR; Myo-Inositol-1-Phosphate Synthase; Neurons; Postmortem Changes; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Saccharomyces cerevisiae; Valproic Acid | 2004 |
Genetic perturbation of glycolysis results in inhibition of de novo inositol biosynthesis.
Topics: Amino Acid Sequence; Base Sequence; DNA Primers; Glycolysis; Inositol; Lithium; Molecular Sequence Data; Mutation; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Triose-Phosphate Isomerase; Valproic Acid | 2005 |
Myo-inositol enhances teratogenicity of valproic acid in the mouse.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anticonvulsants; Drug Synergism; Embryo Loss; Female; Fetal Weight; Injections, Intraperitoneal; Inositol; Mice; Mice, Inbred Strains; Neural Tube Defects; Pregnancy; Species Specificity; Teratogens; Valproic Acid | 2006 |
Specificity of mood stabilizer action on neuronal growth cones.
Topics: Animals; Animals, Newborn; Ganglia, Spinal; Inositol; Lithium Compounds; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Spinal Cord; Valproic Acid | 2007 |
The effect of sodium valproate on proton MRS visible neurochemical concentrations.
Topics: Adolescent; Adult; Algorithms; Anticonvulsants; Brain Chemistry; Dipeptides; Epilepsy; Female; Glutamic Acid; Glutamine; Humans; Inositol; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Valproic Acid | 2007 |
Crystal structure and anticonvulsant activity of (+/-)-1,2:4,5-di-O-isopropylidene-3,6-di-O-(2-propylpentanoyl)-myo-inositol.
Topics: Animals; Anticonvulsants; Carbohydrate Conformation; Crystallography, X-Ray; Electroshock; Inositol; Mice; Pentylenetetrazole; Valproic Acid | 2007 |
Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Brain Chemistry; Carbamazepine; Cerebral Cortex; Hippocampus; Inositol; Lamotrigine; Lithium Carbonate; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Sprague-Dawley; Triazines; Valproic Acid | 2007 |
The mood stabilizer valproate inhibits both inositol- and diacylglycerol-signaling pathways in Caenorhabditis elegans.
Topics: Acetylcholine; Animals; Antimanic Agents; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carrier Proteins; Defecation; Diglycerides; Inositol; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Inositol Phosphates; Muscle Contraction; Mutation; Ovulation; Phosphatidylinositol 4,5-Diphosphate; Signal Transduction; Valproic Acid | 2008 |
Yeast bioassay for identification of inositol depleting compounds.
Topics: Anticonvulsants; Antimanic Agents; Biological Assay; Bipolar Disorder; Brain; Carboxylic Acids; Cell Proliferation; Chronic Disease; Humans; Inositol; Intracellular Space; Lithium Carbonate; Myo-Inositol-1-Phosphate Synthase; Saccharomyces cerevisiae Proteins; Valproic Acid; Yeasts | 2009 |
Ethylbutyrate, a valproate-like compound, exhibits inositol-depleting effects--a potential mood-stabilizing drug.
Topics: Affect; Bipolar Disorder; Butyrates; Cell Proliferation; Humans; Inositol; Intramolecular Lyases; Saccharomyces cerevisiae; Valproic Acid | 2009 |
Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
Topics: Adolescent; Adult; Anticonvulsants; Aspartic Acid; Choline; Creatine; Energy Metabolism; Epilepsies, Myoclonic; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Female; Glutamic Acid; Glutamine; Humans; Hyperammonemia; Image Processing, Computer-Assisted; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Occipital Lobe; Parietal Lobe; Reference Values; Valproic Acid; Young Adult | 2009 |
PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Carbamazepine; Chemotaxis; Humans; Inositol; Lithium Compounds; Phosphatidylinositol Phosphates; Signal Transduction; Valproic Acid | 2009 |
The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium.
Topics: Animals; Anticonvulsants; Dictyostelium; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Inositol; Models, Biological; Mutation; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Rats; Signal Transduction; Time Factors; Valproic Acid | 2012 |
Conserved valproic-acid-induced lipid droplet formation in Dictyostelium and human hepatocytes identifies structurally active compounds.
Topics: Cell Line; Dictyostelium; Fatty Acids; Fatty Liver; Hepatocytes; Humans; Inositol; Kinetics; Lipid Metabolism; Models, Biological; Species Specificity; Teratogens; Valproic Acid | 2012 |
Phosphorylation regulates myo-inositol-3-phosphate synthase: a novel regulatory mechanism of inositol biosynthesis.
Topics: Amino Acid Sequence; Binding Sites; Catalysis; Escherichia coli; Gene Expression Regulation, Enzymologic; Humans; Inositol; Intramolecular Lyases; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Phospholipids; Phosphoproteins; Phosphorylation; Protein Binding; Protein Conformation; Protein Processing, Post-Translational; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Serine; Valproic Acid | 2013 |
Inositol synthesis regulates the activation of GSK-3α in neuronal cells.
Topics: Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Glucose Transport Proteins, Facilitative; Glycogen Synthase Kinase 3; Heat-Shock Proteins; Humans; Inositol; Intracellular Fluid; Intramolecular Lyases; Neuroblastoma; RNA, Messenger; Symporters; Valproic Acid | 2015 |
Perturbation of the Vacuolar ATPase: A NOVEL CONSEQUENCE OF INOSITOL DEPLETION.
Topics: Anticonvulsants; Drug Resistance, Fungal; Gene Deletion; Homeostasis; Inositol; Intramolecular Lyases; Myo-Inositol-1-Phosphate Synthase; Osmotic Pressure; Phosphatidylinositol Phosphates; Protein Transport; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Vacuolar Proton-Translocating ATPases; Vacuoles; Valproic Acid | 2015 |
Inositol Depletion Induced by Acute Treatment of the Bipolar Disorder Drug Valproate Increases Levels of Phytosphingosine.
Topics: Acetyltransferases; Antimanic Agents; Bipolar Disorder; Ceramides; Down-Regulation; Humans; Inositol; Membrane Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sphingosine; Up-Regulation; Valproic Acid | 2017 |
MCK1 is a novel regulator of myo-inositol phosphate synthase (MIPS) that is required for inhibition of inositol synthesis by the mood stabilizer valproate.
Topics: Antimanic Agents; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Inositol; Myo-Inositol-1-Phosphate Synthase; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Valproic Acid | 2017 |
In-silico studies on Myo inositol-1-phosphate synthase of
Topics: Animals; Inositol; Leishmania donovani; Leishmaniasis; Ligands; Mammals; Molecular Dynamics Simulation; Myo-Inositol-1-Phosphate Synthase; Valproic Acid | 2022 |
Phosphatidic acid inhibits inositol synthesis by inducing nuclear translocation of kinase IP6K1 and repression of myo-inositol-3-P synthase.
Topics: AMP-Activated Protein Kinases; Animals; Fibroblasts; Glucose; Humans; Inositol; Lithium; Mammals; Mice; Phosphatidic Acids; Phospholipase D; Phosphotransferases (Phosphate Group Acceptor); Valproic Acid | 2022 |
Safety of inositol supplementation in patients taking lithium or valproic acid: a pilot clinical study.
Topics: Adolescent; Adult; Dietary Supplements; Glucose; Humans; Inositol; Insulin; Lactalbumin; Lithium; Pilot Projects; Quality of Life; Thyrotropin; Triglycerides; Valproic Acid | 2022 |